Your browser doesn't support javascript.
loading
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.
Bikdeli, Behnood; Madhavan, Mahesh V; Jimenez, David; Chuich, Taylor; Dreyfus, Isaac; Driggin, Elissa; Nigoghossian, Caroline Der; Ageno, Walter; Madjid, Mohammad; Guo, Yutao; Tang, Liang V; Hu, Yu; Giri, Jay; Cushman, Mary; Quéré, Isabelle; Dimakakos, Evangelos P; Gibson, C Michael; Lippi, Giuseppe; Favaloro, Emmanuel J; Fareed, Jawed; Caprini, Joseph A; Tafur, Alfonso J; Burton, John R; Francese, Dominic P; Wang, Elizabeth Y; Falanga, Anna; McLintock, Claire; Hunt, Beverley J; Spyropoulos, Alex C; Barnes, Geoffrey D; Eikelboom, John W; Weinberg, Ido; Schulman, Sam; Carrier, Marc; Piazza, Gregory; Beckman, Joshua A; Steg, P Gabriel; Stone, Gregg W; Rosenkranz, Stephan; Goldhaber, Samuel Z; Parikh, Sahil A; Monreal, Manuel; Krumholz, Harlan M; Konstantinides, Stavros V; Weitz, Jeffrey I; Lip, Gregory Y H.
Afiliación
  • Bikdeli B; NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York; Center for Outcomes Research and Evaluation (CORE), Yale School of Medicine, New Haven, Connecticut; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York. Electronic address: bb2813
  • Madhavan MV; NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York. Electronic address: mvm2122@cumc.columbia.edu.
  • Jimenez D; Respiratory Department, Hospital Ramón y Cajal and Medicine Department, Universidad de Alcalá (Instituto de Ramón y Cajal de Investigación Sanitaria), Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Madrid, Spain.
  • Chuich T; NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York.
  • Dreyfus I; NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York.
  • Driggin E; NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York.
  • Nigoghossian C; NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York.
  • Ageno W; Department of Medicine and Surgery, University of Insubria, Varese, Italy.
  • Madjid M; McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas.
  • Guo Y; Department of Cardiology, Chinese PLA General Hospital, Beijing, China.
  • Tang LV; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Hu Y; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Giri J; Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; Penn Cardiovascular Outcomes, Quality, and Evaluative Research Center, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania; Corporal Michael J. Crescenz VA
  • Cushman M; University of Vermont Medical Center, Burlington, Vermont.
  • Quéré I; Department of Vascular Medicine, University of Montpellier, Centre Hospitalier Universitaire Montpellier, InnoVTE F-CRIN Network, Montpellier, France.
  • Dimakakos EP; Oncology Unit GPP, Sotiria General Hospital Athens School of Medicine, Athens, Greece.
  • Gibson CM; Harvard Medical School, Boston, Massachusetts; Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Lippi G; Laboratory of Clinical Chemistry and Hematology, University Hospital of Verona, Verona, Italy.
  • Favaloro EJ; Haematology Laboratory, Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Westmead Hospital, Westmead, New South Wales, Australia; Sydney Centres for Thrombosis and Haemostasis, Westmead, New South Wales, Australia.
  • Fareed J; Loyola University Medical Center, Chicago, Illinois.
  • Caprini JA; Pritzker School of Medicine, University of Chicago, Chicago, Illinois.
  • Tafur AJ; Pritzker School of Medicine, University of Chicago, Chicago, Illinois; Division of Vascular Medicine, Department of Medicine, NorthShore University HealthSystem, Skokie, Illinois.
  • Burton JR; NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York.
  • Francese DP; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York.
  • Wang EY; NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York.
  • Falanga A; Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, University of Milan Bicocca, Bergamo, Italy.
  • McLintock C; Auckland City Hospital, Auckland, New Zealand.
  • Hunt BJ; St Thomas' Hospital, London, United Kingdom.
  • Spyropoulos AC; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hofstra University, Hempstead, New York.
  • Barnes GD; Center for Bioethics and Social Science in Medicine, University of Michigan, Ann Arbor, Michigan; Frankel Cardiovascular Center, University of Michigan, Ann Arbor, Michigan.
  • Eikelboom JW; Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.
  • Weinberg I; Harvard Medical School, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts.
  • Schulman S; Department of Obstetrics and Gynecology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia; McMaster University, Hamilton, Ontario, Canada; Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada.
  • Carrier M; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Piazza G; Harvard Medical School, Boston, Massachusetts; Brigham and Women's Hospital, Boston, Massachusetts.
  • Beckman JA; Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Steg PG; INSERM U1148, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, FACT (French Alliance for Cardiovascular Trials), Paris, France; Université Paris, Paris, France; Royal Brompton Hospital, Imperial College London, London, United Kingdom.
  • Stone GW; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Rosenkranz S; Cologne Cardiovascular Research Center, Heart Center, Department of Cardiology, University of Cologne, Cologne, Germany.
  • Goldhaber SZ; Harvard Medical School, Boston, Massachusetts; Brigham and Women's Hospital, Boston, Massachusetts.
  • Parikh SA; NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York.
  • Monreal M; Department of Internal Medicine, Hospital Universitari Germans Trials i Pujol, Universidad Católica San Antonio de Murcia, Barcelona, Spain.
  • Krumholz HM; Center for Outcomes Research and Evaluation (CORE), Yale School of Medicine, New Haven, Connecticut; Department of Health Policy and Administration, Yale School of Public Health, New Haven, Connecticut; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New
  • Konstantinides SV; Center for Thrombosis and Hemostasis, Johannes Gutenberg University of Mainz, Mainz, Germany.
  • Weitz JI; McMaster University, Hamilton, Ontario, Canada; Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada.
  • Lip GYH; Liverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital, University of Liverpool, Liverpool, United Kingdom; Aalborg University, Aalborg, Denmark.
J Am Coll Cardiol ; 75(23): 2950-2973, 2020 06 16.
Article en En | MEDLINE | ID: mdl-32311448
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neumonía Viral / Tromboembolia / Inhibidores de Agregación Plaquetaria / Infecciones por Coronavirus / Pandemias / Fibrinolíticos / Betacoronavirus / Anticoagulantes Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: J Am Coll Cardiol Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neumonía Viral / Tromboembolia / Inhibidores de Agregación Plaquetaria / Infecciones por Coronavirus / Pandemias / Fibrinolíticos / Betacoronavirus / Anticoagulantes Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: J Am Coll Cardiol Año: 2020 Tipo del documento: Article